Primary Location

Eugene
520 Country Club Road
Eugene, Oregon 97401

View Eugene location

Phone: 541-683-5001
Fax: 541-683-1422

Patient Care Philosophy

Compassionate and attentive, Dr. Emily Dunn believes in individualized care tailored to the needs of the patient.

As a radiation oncologist, Dr. Dunn understands how important it is for patients to feel connected to their oncologist. She fosters that patient-provider relationship by taking the time to get to know them.

“Spending quality time face-to-face with my patients creates a better understanding for them of their diagnosis and treatment, and it gives me insight into their wishes and fears. Being allowed into a person’s life, to care for them during such a challenging time, is a privilege.”

She chose radiation oncology because of its precision in treating cancer and its ever-evolving advancements in technology.

“The dynamically changing field of radiation oncology, the pace at which we’re learning about cancer, and the treatments we’re able to provide patients is exciting.”

Personal Information

Dr. Dunn devotes her free time to her husband and two young boys. She and her family enjoy many outdoor activities, from fishing to hiking and kayaking to snowboarding. Dr. Dunn and her husband are both former collegiate track athletes and love the perks of having TrackTown USA be their home.

Board Certifications

Radiation Oncology

Special Interest

Fellowship

University of Wisconsin

Residency

University of Wisconsin

Medical School

Sanford School of Medicine at University of South Dakota

American Society for Therapeutic Radiology and Oncology (ASTRO)
American Brachytherapy Society (ABS)

Robbins, J.B., Dunn, E.F., Bradley, K.A., Brittin, J.J., Munoz Del Rio, A., Sadowski, E.A. Assessment of Cervical Cancer Using Blood Oxygen-Level Dependent and Diffusion Weighted Magnetic Resonance Imaging. Int J Radiol Imaging Technol. 2015, 1:1.
Editorial: The Case for Brachytherapy in the Elderly, Brachyblast, July 2017
The role of Src in solid tumors
Understanding resistance to EGFR inhibitors-impact on future treatment strategies
Ultraviolet Germicidal Irradiation to Decontaminate Filtering Face Piece Respirators During COVID-19 Pandemic
COVID-19 impact on timing of brachytherapy treatment and strategies for risk mitigation
Effect of COVID-19 on Gynecologic Oncology Care: A Survey of Practicing Gynecologic Radiation Oncologists in the United States
Nuclear Epidermal Growth Factor Receptor Is a Functional Molecular Target in Triple-negative Breast Cancer
Evaluating an Ultraviolet C System for Use During SARS-CoV2 Pandemic and Personal Protective Equipment Shortage
Effects of treatment duration during concomitant chemoradiation therapy for cervical cancer
Erlotinib is a viable treatment for tumors with acquired resistance to cetuximab
External beam radiotherapy for colon cancer: patterns of care
Epidermal growth factor receptor cooperates with Src family kinases in acquired resistance to cetuximab
Predictive factors of recurrence following adjuvant vaginal cuff brachytherapy alone for stage I endometrial cancer
Severe late toxicities following concomitant chemoradiotherapy compared to radiotherapy alone in cervical cancer: an inter-era analysis
Dasatinib blocks cetuximab- and radiation-induced nuclear translocation of the epidermal growth factor receptor in head and neck squamous cell carcinoma
BB, a novel epidermal growth factor receptor inhibitor

Emily Dunn, MD

Radiation Oncologist